Journal Article

Simultaneous Expression of CD70 and POSTN in Cancer-Associated Fibroblasts Predicts Worse Survival of Colorectal Cancer Patients

Takahashi, Satoru, Wang, Chengbo, Kasai, Kenji, Kato, Shunsuke, Ito, Sunao, Inaguma, Shingo, Ebi, Masahide, Komura, Masayuki, Takiguchi, Shuji, Kasugai, Kunio, Tsuzuki, Toyonori, Ogasawara, Naotaka, Ueki, Akane

2024

Overview

Colorectal cancer (CRC) is one of the most common gastrointestinal cancers worldwide, with high morbidity and mortality rates. The evidence for the tumor-supporting capacities of cancer-associated fibroblasts (CAFs) that modulate cancer cell proliferation, invasion, metastasis, and tumor immunity, including in CRC, has been attracting attention. The present study examined the expression status of CD70 and POSTN in CRC and analyzed their association with clinicopathological features and clinical outcomes. In the present study, in total 15% (40/269) and 44% (119/269) of cases exhibited CD70 and POSTN expression on CAFs, respectively. Co-expression of CD70 and POSTN was detected in 8% (21/269) of patients. Fluorescent immunohistochemistry identified the co-expression of CD70 and POSTN with FAP and PDPN, respectively. ACTA2 was not co-expressed with CD70 or POSTN in CRC CAFs. CRC with CD70+/POSTN+ status in CAFs was significantly associated with distant organ metastasis (p = 0.0020) or incomplete resection status (p = 0.0011). CD70+/POSTN+ status tended to associate with advanced pT stage (p = 0.032) or peritoneal metastasis (p = 0.0059). Multivariate Cox hazards regression analysis identified CD70+/POSTN+ status in CAFs [hazard ratio (HR) = 3.78] as a potential independent risk factor. In vitro experiments revealed the activated phenotypes of colonic fibroblasts induced by CD70 and POSTN, while migration and invasion assays identified enhanced migration and invasion of CRC cells co-cultured with CD70- and POSTN-expressing colonic fibroblasts. On the basis of our observations, CD70 and POSTN immunohistochemistry can be used in the prognostication of CRC patients. CRC CAFs may be a promising target in the treatment of CRC patients.

• Publisher: MDPI AG,MDPI
• Subject: B cells / Cancer patients / Cancer-Associated Fibroblasts - metabolism / CD27 Ligand - metabolism / Cell Adhesion Molecules - metabolism / Cell Proliferation / Colorectal cancer / Colorectal Neoplasms - pathology / Fibroblasts / Fibroblasts - metabolism / Gene expression / Humans / Immunohistochemistry / Japan / Medical research / Medicine, Experimental / Metastasis / Mortality / Patient outcomes / Physiology / Risk factors / Tumor necrosis factor-TNF